World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
126
Citations
87823
World Ranking
2880
National Ranking
294

Research.com Recognitions

  • 2003 - Fellow of the Royal Society of Edinburgh

Overview

Chris J. Packard is affiliated with the Glasgow Royal Infirmary in the United Kingdom. Their research primarily focuses on the areas of biochemistry, genetics, and molecular biology, as well as medicine. Within these broad fields, subfields such as cancer research and surgery have been significant in their work.

Their published output includes research on topics related to cancer, lipids, and metabolism, alongside lipoproteins and cardiovascular health.

  • Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER (2020, UNC Libraries)

Chris J. Packard has collaborated with several frequent co-authors in their research efforts, including:

  • Eliana Polisecki
  • Hind Muallem
  • Nobuyo Maeda
  • Inga Peter
  • Michele Robertson

Their work has been published notably in venues such as UNC Libraries.

Recognition within their professional community includes the award of Fellow of the Royal Society of Edinburgh in 2003.

Best Publications

  • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

    J Shepherd;S M Cobbe;I Ford;C G Isles

  • Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

    James Shepherd;Gerard J Blauw;Michael B Murphy;Edward Lem Bollen

  • Major lipids, apolipoproteins, and risk of vascular disease

    E Di Angelantonio;N Sarwar;P Perry

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study

    Naveed Sattar;Allan Gaw;Olga Scherbakova;Ian Ford

  • West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials

    J Shepherd;SM Cobbe;AR Lorimer;JH McKillop

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard

  • Pravastatin and the Development of Diabetes Mellitus Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study

    Dilys J. Freeman;John Norrie;Naveed Sattar;R. Dermot G. Neely

  • C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

    Stephen Kaptoge;Emanuele Di Angelantonio;Lisa Pennells;Angela M. Wood

  • Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS)

    A M Wallace;A D McMahon;C J Packard;A Kelly

  • Lipoprotein-Associated Phospholipase A2 as an Independent Predictor of Coronary Heart Disease

    Chris J. Packard;Denis S. J. O'reilly;Muriel J. Caslake;Alex D. Mcmahon

  • C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study

    Dilys J. Freeman;John Norrie;Muriel J. Caslake;Allan Gaw

  • Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study

    Scott W Brouilette;Jasbir S Moore;Alex D McMahon;John R Thompson

  • SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

    Steven Hageman;Lisa Pennells

  • Overproduction of large VLDL particles is driven by increased liver fat content in man.

    Martin Adiels;M. R. Taskinen;C. Packard;M. J. Caslake

  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    Jane Armitage;Colin Baigent;Elizabeth Barnes;D John Betteridge

  • Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

    CJ Packard;J Shepherd;SM Cobbe;Jane B Ford

  • Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk.

    Bruce A. Griffin;Dilys J. Freeman;Graeme W. Tait;Jim Thomson

  • Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

    G. Eiriksdottir;T. B. Harris;L. J. Launer;V. Gudnason

Frequent Co-Authors

Ian Ford
Ian Ford University of Glasgow
Naveed Sattar
Naveed Sattar University of Glasgow
James Shepherd
James Shepherd University of Glasgow
J. Wouter Jukema
J. Wouter Jukema Leiden University Medical Center
Peter W. Macfarlane
Peter W. Macfarlane University of Glasgow
Stella Trompet
Stella Trompet Leiden University Medical Center
Stuart M. Cobbe
Stuart M. Cobbe University of Glasgow
John Danesh
John Danesh University of Cambridge
Rudi G. J. Westendorp
Rudi G. J. Westendorp University of Copenhagen
Marja-Riitta Taskinen
Marja-Riitta Taskinen University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you consider studying Medicine in the USA, it's important to explore related online degrees and alternative pathways in healthcare. For those interested in preventative care and wellness, a nutritionist online degree can open doors to careers in dietary planning, health education, and community outreach.

Healthcare administration is another growing field, offering leadership roles in hospitals and clinics. Prospective students should research which online healthcare administration programs have cahme accreditation? to ensure they enroll in respected, career-advancing programs. Accreditation is key for credibility and future employment.

For registered nurses ready to move forward, the flexibility of a rn to bsn online no clinicals accredited program makes it easier to balance work and studies, with options available for those who prefer to complete coursework without additional clinical hours.

Nurses aiming for the highest credentials may consider dnp online programs, which can be completed more efficiently through flexible or accelerated formats. These pathways all offer specialized skills that support dynamic healthcare careers beyond traditional medical school.

Best Scientists Citing Chris J. Packard

Trending Scientists

Recently Published Articles